{
    "root": "3468bd16-04d3-d752-e063-6294a90a116e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Trazodone Hydrochloride",
    "value": "20250505",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        }
    ],
    "indications": {
        "text": "trazodone hydrochloride tablets indicated treatment major depressive disorder ( mdd ) adults .",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "starting dose : 150 mg divided doses daily . may increased 50 mg per day every three four days . maximum dose : 400 mg per day divided doses ( 2 ) . trazodone hydrochloride tablets taken shortly meal light snack ( 2 ) . tablets swallowed whole broken half along score line , chewed crushed ( 2 ) . discontinued , gradual dose reduction recommended ( 2 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "trazodone hydrochloride tablets , usp available follows : 50 mg : white , round , compressed tablet , debossed \u201c pliva 433 \u201d one side scored side . available ndc : 70518-2929-00 ndc : 70518-2929-01 ndc : 70518-2929-02 ndc : 70518-2929-03 ndc : 70518-2929-04 ndc : 70518-2929-05 ndc : 70518-2929-06 ndc : 70518-2929-07 packaging : 30 1 blister pack packaging : 90 1 bottle plastic packaging : 30 1 blister pack packaging : 90 1 bottle plastic packaging : 60 1 blister pack packaging : 100 1 box packaging : 1 1 pouch packaging : 30 1 bottle plastic directions using correct score breaking tablet please refer following : - 50 mg , break score either left right side tablet ( one-third tablet ) . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp . keep medications reach children . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "trazodone hydrochloride tablets contraindicated : patients taking , within 14 days stopping , monoamine oxidase inhibitors ( maois ) , including maois linezolid intravenous methylene blue , increased risk serotonin syndrome [ ( 5.2 ) , ( 7.1 ) ] .",
    "indications_original": "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults.",
    "contraindications_original": "Starting dose: 150 mg in divided doses daily. May be increased by 50 mg per day every three to four days. Maximum dose: 400 mg per day in divided doses ( 2 ). Trazodone hydrochloride tablets should be taken shortly after a meal or light snack ( 2 ). Tablets should be swallowed whole or broken in half along the score line, and should not be chewed or crushed ( 2 ). When discontinued, gradual dose reduction is recommended ( 2 ).",
    "warningsAndPrecautions_original": "Trazodone hydrochloride tablets, USP are available as follows:\n                  50 mg: White, round, compressed tablet, debossed \u201cPLIVA 433\u201d on one side and scored on the other side. Available in\n                  NDC: 70518-2929-00\n                  NDC: 70518-2929-01\n                  NDC: 70518-2929-02\n                  NDC: 70518-2929-03\n                  NDC: 70518-2929-04\n                  NDC: 70518-2929-05\n                  NDC: 70518-2929-06\n                  NDC: 70518-2929-07\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 60 in 1 BLISTER PACK\n                  PACKAGING: 100 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC \n                  \n                  \n                  Directions for using the correct score when breaking the tablet please refer to the following:\n                  - For 50 mg, break the score on either the left or right side of the tablet (one-third of a tablet).\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP.\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Trazodone hydrochloride tablets are contraindicated in:\n                  \n                     \n                        Patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome \n         \n   \n    [see Warnings and Precautions (\n          \n    \n     5.2), Drug Interactions (\n          \n    \n     7.1)].",
    "drug": [
        {
            "name": "Trazodone Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        }
    ]
}